Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants

Archives of Pharmacal Research

Volumn 34, Issue 11, 2011, Pages 1945-1956

  Sheshala, Ravi ^a,b   Khan, Nurzalina ^a   Chitneni, Mallikarjun ^a,b   Darwis, Yusrida ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Disintegration time; Ondansetron; Orally disintegrating tablets; Pharmacokinetic study; Superdisintegrants; Wet granulation

Indexed keywords

CROSPOVIDONE; MICROCRYSTALLINE CELLULOSE; ONDANSETRON;

ADULT; ANIMAL EXPERIMENT; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG GRANULATION; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NORMAL HUMAN; TABLET DISINTEGRATION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET PROPERTY; TABLET THICKNESS; TASTE; WATER CONTENT;

ADMINISTRATION, ORAL; ADULT; ANIMALS; ANTIEMETICS; BIOLOGICAL AVAILABILITY; DRUG COMPOUNDING; DRUG STABILITY; EXCIPIENTS; HUMANS; MALE; ONDANSETRON; PHYSICOCHEMICAL PHENOMENA; RABBITS; RANDOM ALLOCATION; SENSATION; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; SOLUBILITY; SWEETENING AGENTS; TABLETS; TASTE;

EID: 83655182577     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-1115-y     Document Type: Article

References (35)

1. Ahmed, S. U., Gorukanti, S. R., and Chowdhury, T. A., Ondansetron orally disintegrating tablets. U.S. Patent 7,390,503 (2008).
2. Balasubramaniam, J. and Bee, T., Influence of superdisintegrants on the rate of drug dissolution from oral solid dosage forms. Pharm. Tech. Suppl., S4-S14 (2009).
3. N. S. Barakat I. M. Elbagory A. S. Almurshedi 2009 Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components Drug Deliv. 16 57 65 19555310 10.1080/10717540802518157 1:CAS:528:DC%2BD1MXktVWrtbY%3D
4. BASF, Superdisintegrants and dissolution enhancers. http://www.pharma- ingredients.basf.com/Home.aspx (2010).
5. S. K. Battu M. A. Repka S. Majumdar R. Y. Madhusudan 2007 Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants Drug Dev. Ind. Pharm. 33 1225 1232 18058319 10.1080/03639040701377888 1:CAS:528:DC%2BD2sXhtlOjs7nN (Pubitemid 350208742)
6. Y. Bi H. Sunada Y. Yonezawa K. Danjo A. Otsuka K. Iida 1996 Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity Chem. Pharm. Bull. (Tokyo) 44 2121 2127 1:CAS:528:DyaK28Xnt1yjt7o%3D (Pubitemid 26396765)
7. R. K. Chang X. Guo B. A. Burnside R. A. Couch 2000 Fast-dissolving tablets Pharm. Technol. 24 52 58 1:CAS:528:DC%2BD3cXksl2lur8%3D (Pubitemid 30450499)
8. S. Corveleyn J. P. Remon 1999 Stability of freeze-dried tablets at different relative humidities Drug Dev. Ind. Pharm. 25 1005 1013 10518240 10.1081/DDC-100102263 1:CAS:528:DyaK1MXmtl2qtb0%3D (Pubitemid 29457930)
9. H. Goel N. Vora A. K. Tiwary V. Rana 2009 Formulation of orodispersible tablets of ondansetron HCl: investigations using glycine-chitosan mixture as superdisintegrant Yakugaku Zasshi 129 513 521 19420882 10.1248/yakushi.129.513 1:CAS:528:DC%2BD1MXotFGhtLc%3D
10. H. Goel N. Vora A. K. Tiwary V. Rana 2009 Understanding the mechanism for paradoxical effect of ionized and unionized chitosan: Orodispersible tablets of Ondansetron Hydrochloride Pharm. Dev. Technol. 14 476 484 19241220 10.1080/10837450902749279 1:CAS:528:DC%2BD1MXhtFWhu7%2FJ
11. Hahm, H. A. and Augsburger, L. L., Orally disintegrating tablets and related tablet formulations, In Hoag, S. W. and Augsburger, L. L. (Eds.). Pharmaceutical Dosage Forms: Tablets. Informa Healthcare, New York, pp. 293-312, (2008).
12. D. Indhumathi G. Rathnam 2010 Design and optimization of orodissolving tablet of antidepressant drug by superdisintegrants addition method Int. J. Pharm. Sci. Rev. Res. 2 1 9 1:CAS:528:DC%2BC3cXnvFSmt7g%3D
13. T. Ishikawa N. Koizumi B. Mukai N. Utoguchi M. Fujii M. Matsumoto H. Endo S. Shirotake Y. Watanabe 2001 Pharmacokinetics of acetaminophen from rapidly disintegrating compressed tablet prepared using microcrystalline cellulose (PH-M-06) and spherical sugar granules Chem Pharm Bull. (Tokyo) 49 230 232 10.1248/cpb.49.230 1:CAS:528:DC%2BD3MXhtVSitLo%3D (Pubitemid 32174661)
14. S. Jeevanandham D. Dhachinamoorthi K. B. Chandra Sekhar M. Muthukumaran N. Sriram J. Joysaruby 2010 Formulation and evaluation of naproxen sodium orodispersible tablets - A sublimation technique Asian J. Pharm. 4 48 51 10.4103/0973-8398.63985 1:CAS:528:DC%2BC3MXhsFWitrbP
15. S. H. Jeong Y. Takaishi Y. Fu K. Park 2008 Material properties for making fast dissolving tablets by a compression method J. Mater. Chem. 18 3527 3535 10.1039/b800209f 1:CAS:528:DC%2BD1cXoslOhtL0%3D
16. A. A. Joshi X. Duriez 2004 Added functionality excipients: an answer to challenging formulations Pharm. Technol. 12 12 19
17. S. Khan P. Kataria P. Nakhat P. Yeole 2007 Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets AAPS PharmSciTech 8 E127 E133 10.1208/pt0802046
18. J. Klancke 2003 Dissolution testing of orally disintegrating tablets Dissolution Technol. 10 6 8 1:CAS:528:DC%2BD3sXltVSns74%3D
19. Y. Kuno M. Kojima H. Nakagami E. Yonemochi K. Terada 2008 Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol Eur. J. Pharm. Biopharm. 69 986 992 18396020 10.1016/j.ejpb.2008.02.016 1:CAS:528: DC%2BD1cXpt1GqtLg%3D
20. S. Malke S. Shidhaye V. J. Kadam 2007 Formulation and evaluation of oxcarbazepine fast dissolve tablets Indian J. Pharm. Sci. 69 211 214 10.4103/0250-474X.33145 1:CAS:528:DC%2BD1MXhtVGqsLrI (Pubitemid 47026101)
21. Marshall, K. and Rudnic, E. M., Tablet dosage forms, In Banker, G. S. and Rhodes, C. T. (Eds.). Modern pharmaceutics. Marcel Dekker, New York, pp. 355-425, (1990).
22. D. N. Mishra M. Bindal S. K. Singh S. G. Vijaya Kumar 2006 Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets Chem. Pharm. Bull. (Tokyo) 54 99 102 10.1248/cpb.54.99 1:CAS:528:DC%2BD28Xjslehsbk%3D (Pubitemid 43036758)
23. A. Mohapatra R. K. Parikh M. C. Gohel 2008 Formulation, development and evaluation of patient friendly dosage forms of metformin, Part-I: Orally disintegrating tablets Asian J. Pharm. 2 167 171 10.4103/0973-8398.43304
24. D. M. Patel N. M. Patel R. R. Shah P. D. Jogani A. I. Balapatel 2004 Studies in formulation of orodispersible tablets of rofecoxib Indian J. Pharm. Sci. 66 621 625 1:CAS:528:DC%2BD2cXhtFShsr7E
25. D. M. Patel M. M. Patel 2008 Optimization of fast dissolving etoricoxib tablets prepared by sublimation technique Indian J. Pharm. Sci. 70 71 76 20390084 10.4103/0250-474X.40335 1:STN:280:DC%2BC3c3mtVOitw%3D%3D (Pubitemid 351670572)
26. Quadir, A. and Kolter, K., A comparative study of current superdisintegrants. Pharm. Tech., 30, S38-S42 (2006).
27. Rowe, R. C., Sheskey, P. J., and Weller, P. J., Handbook of pharmaceutical excipients. Pharmaceutical Press, London, (2003).
28. C. M. Setty D. V. K. Prasad V. R. M. Gupta B. Sa 2008 Development of fast dispersible aceclofenac tablets: Effect of functionality of superdisintegrants Indian J. Pharm. Sci. 70 180 185 20046709 10.4103/0250-474X.41452 (Pubitemid 351920193)
29. Shasaku, K., Fast disintegrating formulations of anirectam. JPN. Patent 11,13,662 (1999).
30. R. Sheshala Y. Darwis N. Khan 2009 Development and validation of an RP-LC-UV method for the determination of ondansetron: Application to pharmaceutical dosage forms Chromatographia 70 75 81 10.1365/s10337-009-1117-9 1:CAS:528:DC%2BD1MXhtVOktLvL
31. D. Shukla S. Chakraborty S. Singh B. Mishra 2009 Fabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tablets. Chem Pharm. Bull. (Tokyo) 57 337 345 10.1248/cpb.57.337 1:CAS:528:DC%2BD1MXmtl2gtr0%3D
32. P. V. Swamy S. H. Areefulla S. B. Shirsand S. Gandra B. Prashanth 2007 Orodispersible tablets of meloxicam using disintegrant blends for improved efficacy Indian J. Pharm. Sci. 69 836 840 10.4103/0250-474X.39448 1:CAS:528:DC%2BD1MXhtVGqsbfO (Pubitemid 351380207)
33. G. H. P. Te Wierik G. K. Bolhuis 1992 Improvement of dissolution of poorly soluble drugs by solid deposition on a superdisintigrants. I. Physical mixture Acta Pharm. Nord. 4 239 244 (Pubitemid 23031584)
34. US FDA, Inactive Ingredients Search for Approved Product Drugs. http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm (2009). USP 30. US Pharmacopeial Convention, Rockville, MD, pp. 2803-2804, (2007).
35. Wagner, J. G., Statistics: Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton, (1975).